The vast majority of our patient cohort had received prior IFN-based anti-viral therapy and IFN may induce autoimmune disorders or worsen pre-existing autoimmune disorders [32], so it will be important to establish whether the prevalence of anti-apoA-1 IgG is similar in untreated HCV infection. Here, APOA1 is linked to autoimmune disease.